News

In our latest BioRxiv preprint we discover a covalent recruiter against the E2 ubiquitin conjugating enzymes UBE2D which we use to degrade BRD4 and androgen…

We posted our BioRxiv preprint on our discovery of a covalent fumarate-based chemical handle that targets RNF126 that can be transplanted onto a broad range…

July 28th, 2022 Novartis-Berkeley Translational Chemical Biology Institute combines Novartis expertise in chemical biology and medicinal chemistry with Berkeley’s expertise in covalent chemoproteomics and chemistry methodologiesResearch…

Financing led by a16z and Deerfield Management with participation from Droia Ventures, GV, The Mark Foundation for Cancer Research and the Berkeley Catalyst Fund Exclusive…

The NCI Outstanding Investigator Award (OIA) supports investigators with outstanding records of productivity in cancer research by providing extended funding stability and encouraging investigators to…

Nate Henning and Lydia Boike in our lab graduated with their Ph.D. in Chemical Biology from UC Berkeley! Congrats!!

Congrats to co-first authors Nate Henning and Lydia Boike! https://www.nature.com/articles/s41589-022-00971-2.pdf

Excited to share the newest discovery and BioRxiv preprint from our Novartis-Berkeley Center for Proteomics and Chemistry Technologies on the development of a new induced…

Congrats to chemical biology graduate student Nate Henning for passing his qualifying exam!!

Congrats to chemical biology graduate student Bridge Belcher for passing her qualifying exam!